Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 7
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Neel Desai, M.d, M.D | Ophthalmology | Largo, FL | $559.26 | $0 |
| Amir Hossein Marvasti | Ophthalmology | Orange, CA | $529.37 | $0 |
| Dan Tran, M.d, M.D | Specialist | Long Beach, CA | $529.36 | $0 |
| Soren Gantt, Md, MD | Pediatrics | Seattle, WA | $500.00 | $0 |
| Dr. Marnix Heersink, Md, MD | Ophthalmology | Dothan, AL | $481.31 | $0 |
| Darrell Pickard, M.d, M.D | Ophthalmology | Midwest City, OK | $471.14 | $0 |
| Dr. Donald Downer, M.d, M.D | Ophthalmology | Orange Park, FL | $470.46 | $0 |
| Dr. Gerald Appel, M.d, M.D | Nephrology | New York, NY | $455.40 | $0 |
| Dr. Rajiv Rugwani, Md, MD | Ophthalmology | Waxahachie, TX | $426.80 | $0 |
| Edwin Apenbrinck, M.d, M.D | Ophthalmology | Jeffersonville, IN | $411.76 | $0 |
| Dr. Scott Spector, Md, MD | Ophthalmology | Norwalk, CT | $402.20 | $0 |
| Dr. Stephen Kondash, M.d, M.D | Ophthalmology | Cincinnati, OH | $389.31 | $0 |
| Dr. Brenton Finklea, M.d, M.D | Ophthalmology | Bala Cynwyd, PA | $381.86 | $0 |
| Bethany Bray, M.d, M.D | Ophthalmology | West Columbia, SC | $376.31 | $0 |
| Dr. Jonathan Frantz, Md, MD | Ophthalmology | Fort Myers, FL | $374.77 | $0 |
| Dr. Howard Kornstein, M.d, M.D | Ophthalmology | White Plains, NY | $371.02 | $0 |
| Dr. Herbert Gould, M.d, M.D | Specialist | Gaithersburg, MD | $371.02 | $0 |
| Dr. Matthew Shulman, M.d, M.D | Ophthalmology | Miami, FL | $366.30 | $0 |
| Richard Najac, Md, MD | Ophthalmology | Flushing, NY | $362.17 | $0 |
| Russell Vannorman, M.d, M.D | Ophthalmology | Shreveport, LA | $361.93 | $0 |
| Dr. James Guildford, Md, MD | Retina Specialist | West Palm Beach, FL | $359.26 | $0 |
| Paul Sidoti, Md, MD | Ophthalmology | New York, NY | $358.19 | $0 |
| Dr. Richard Koplin, M.d, M.D | Ophthalmology | New York, NY | $355.97 | $0 |
| Dr. Anita Nevyas-Wallace, M.d, M.D | Specialist | Bala Cynwyd, PA | $348.90 | $0 |
| Bradley Black, Md, MD | Ophthalmology | Jeffersonville, IN | $348.39 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.